Request Trial
upc-image-aug-27
F. JIMENEZ MECA/shutterstock.com
4 April 2023FeaturesAmericasChristopher Sharp, Sarah Taylor, Robert Greene Sterne and Nirav Desai

Why the UPC will be rewarding for US businesses

Patents are presently enforced and challenged in Europe on a country-by-country basis. National decisions may be inconsistent, relief is confined to smaller markets, and—compared with US patent litigation—the potential for large damages awards is limited.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
LSPN Awards USA returns for second year—with new categories
3 February 2026   Nominations are open for the Life Sciences Patent Network's 2026 awards in Boston, including six new categories and winners selected by leading industry experts.
Americas
Sanofi suffers setback in insulin monopoly dispute
29 January 2026   A judge has allowed antitrust claims against the pharma giant to move forward, finding that it plausibly used bundled rebates and patent abuse to extend its insulin monopoly, though one allegation was dismissed.
Americas
Eli Lilly’s Mounjaro tops list of cyber squatter targets
28 January 2026   The rise of fake online stores selling counterfeit pharmaceuticals is driving a surge in domain name disputes, forcing major brands to defend revenue and reputation.


Editor's picks

AstraZeneca partners with Chinese firm ahead of next obesity race
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026

Editor's picks

Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025

More features

INTA: ‘Davos of IP’ will take London meeting to a ‘different level’
Nine-partner litigation team leaves Winston & Strawn
Squire Patton Boggs brings in tech and data expert as Ireland practice lead
LSPN Awards USA returns for second year—with new categories
Crowell adds tech partner with in-house and private practice expertise
Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger
Sanofi suffers setback in insulin monopoly dispute
Firm adds seven-lawyer team in second major merger